Dr. Weiping Zhu 朱卫平
Chief Physician
Department of Liver Surgery, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive treatment of primary and metastatic liver tumors, including hepatocellular carcinoma and colorectal cancer metastases. Management of biliary tract tumors such as gallbladder cancer and hilar cholangiocarcinoma.
Dr. Zhu holds a medical doctorate from Fudan University Shanghai Medical College and has over 20 years of experience in liver surgery. A visiting scholar at the University of Tokyo Hospital, Dr. Zhu serves as Executive Deputy Director of the Liver Cancer Diagnosis and Treatment Center at Fudan University Shanghai Cancer Center Fujian Hospital. Research focuses on clinical intervention and mechanisms of liver tumor metastasis and recurrence.
Professional roles
- Member, Hepato-Pancreato-Biliary Surgery ERAS Committee, China Branch of International Hepato-Pancreato-Biliary Association
- Member, Accelerated Recovery Tumor Surgery Committee, China Anti-Cancer Association
- Member, Comprehensive Treatment of Hepatobiliary Tumors Committee, Shanghai Anti-Cancer Association
- Member, Tumor Psychology Professional Committee, Shanghai Anti-Cancer Association
Name order: in Chinese the family name comes first (Zhu Weiping). Papers usually list the name as Weiping Zhu or Zhu W.
Selected publications
32 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- Drug Discov Ther, 2026 (first author): The conversion window in hepatocellular carcinoma: When resectability alone is not an indication for surgery. PubMed 42802049
- NPJ Digit Med, 2026 (senior author): Combining AI to reveal CCDC3-mediated pathways of colorectal cancer liver metastasis. PubMed 41792471
- Diagnostics (Basel), 2025 (senior author): Gallbladder Schwannoma: A Case Report and Literature Review. PubMed 41300852
- Biosci Trends, 2025 (senior author): A technological convergence in hepatobiliary oncology: Evolving roles of smart surgical systems. PubMed 40754418
- J Exp Clin Cancer Res, 2025 (senior author): SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming. PubMed 40682115
- AMB Express, 2025 (senior author): Genetic evidence for causal links between diet, gut microbiota, and hepatobiliary cancer: a Mendelian randomization study. PubMed 40613843
- Biosci Trends, 2025 (senior author): Advances in research on receptor heterogeneity in breast cancer liver metastasis. PubMed 40240168
- Biosci Trends, 2025 (senior author): Artificial intelligence in colorectal cancer liver metastases: From classification to precision medicine. PubMed 40240167
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion